All Publications
2024
Bertozzi F., Mazzarella M. A., Bottegoni G., Ricci F., Russo D., Penna I., Reggiani A., Bandiera T.
Multitarget-directed Ligands for Multiple Sclerosis with combined Anti-inflammatory and Remyelinating properties (MARs)
Congresso Scientifico Annuale Associazione Italiana Sclerosi Multipla e la sua Fondazione
Poster
Conference
2023
Demuro S., Di Martino R.M.C., Sauvey C., Tripathi S.K., Ortega J. A., Russo D., Penna I., Myers S. H., Bandiera T., Girotto S., Abagyan R., Cavalli A.
Design and synthesis of triple protein kinase inhibitors: paving the way towards novel CNS tools to reverse the aberrant tau phosphorylation
ACS Spring 2023 meeting
Poster
Conference
2022
Demuro S., Sauvey C., Tripathi S.K., Di Martino R.M.C., Shi D., Ortega J.A., Russo D., Balboni B., Giabbai B., Storici P., Girotto S., Abagyan R., Cavalli A.
ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders
European Journal of Medicinal Chemistry, vol. 229
2022
Orioli R., Marotta G., Russo D., Penna I., Rosini M., Ortega J.A., Minarini A.
DESIGN AND SYNTHESIS OF AMMINOTIAZOLE DERIVATIVES AS DUAL LIGANDS TO GSK-3B AND FYN IN THE STUDY OF NEURODEGENERATIVE DISEASES
XXI Giornata della Chimica dell'Emilia Romagna (Bologna)
Poster
Conference
2022
Demuro S., Di Martino R.M.C., Ortega J.A., Sauvey C., Shi D., Tripathi S., Balboni B., Girotto S., Russo D., Penna I., Bandiera T., Ballatore C., Abagyan R., Cavalli A.
Development of multitarget-directed ligands (MTDLs) protein kinases inhibitors to tackle central nervous system (CNS)-related disorders
ACS Spring 2022 meeting
Abstract Report
Conference
Colleagues of D3 PharmaChemistry
